Bank of New York Mellon Corp

Bank

Position in NMRA — Neumora Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in NMRA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$420,825

+$344,422 QoQ

Shares Held

247,545

+531.8% QoQ

Ownership

0.132%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 111 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. NMRA ranks #252 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,672,623	$830,842,010
2	REGN	Regeneron Pharmaceuticals, Inc.	758,492	$472,950,091
3	JAZZ	Jazz Pharmaceuticals plc	1,578,013	$380,253,782
4	ALNY	Alnylam Pharmaceuticals, Inc.	492,071	$148,128,128
5	INSM	INSMED Inc	1,312,756	$139,966,036
6	MRNA	Moderna, Inc.	1,701,675	$119,168,293
7	RVMD	Revolution Medicines, Inc.	601,056	$112,565,759
8	INCY	Incyte Corp	972,825	$110,279,435

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$420,825	247,545	+531.8%	Shares	Defined	2026-08-06
2026-03-31	$76,403	39,182	+0.0%	Shares	Defined	2026-05-05
2025-12-31	$70,133	39,181	+97.5%	Shares	Defined	2026-02-10
2025-09-30	$36,101	19,836	0.0%	Shares	Defined	2025-11-03
2025-06-30	$14,539	19,836	-91.3%	Shares	Defined	2025-08-05
2025-03-31	$227,855	227,855	+5.5%	Shares	Defined	2025-04-29
2024-12-31	$2,288,348	215,882	-0.3%	Shares	Defined	2025-02-04
2024-09-30	$2,859,052	216,431	-8.1%	Shares	Defined	2024-11-12
2024-06-30	$2,315,878	235,593	+474.1%	Shares	Defined	2024-07-25
2024-03-31	$564,216	41,034	-9.2%	Shares	Defined	2024-04-25
2023-12-31	$770,659	45,200	—	Shares	Defined	2024-01-29
No filing history on record for this holder in this stock.